Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Purpose

A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.

Condition

  • Fetal and Neonatal Alloimmune Thrombocytopenia

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pregnant women (≥ 18 years of age) who have provided informed consent for the study.

Exclusion Criteria

  • Participants with prior history of FNAIT

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Pregnant women Women with higher risk of FNAIT
  • Other: Clinical data collection
    Laboratory tests, Vital assessments, Maternal and fetal genotype testing, Antibodies Testing will be performed.

Recruiting Locations

The University of Texas Health Science Center at Houston
Houston, Texas 77030

More Details

Status
Recruiting
Sponsor
Rallybio IPA, LLC

Study Contact

Chief Medical Officer
(203) 859-3820
clinicaltrials@rallybio.com